Published in Eur Respir J on March 01, 1993
Asthmatic airway inflammation is more closely related to airway hyperresponsiveness to hypertonic saline than to methacholine. Korean J Intern Med (2003) 0.84
Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.84
Capsaicin sensitivity in patients with chronic cough- results from a cross-sectional study. Cough (2013) 0.78
Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial. BMC Pulm Med (2011) 0.76
Breathing exercises for asthma: panacea or placebo? Thorax (2007) 0.75
'Indirect' challenges from science to clinical practice. Eur Clin Respir J (2016) 0.75
Role of bronchoprovocation tests in identifying exercise-induced bronchoconstriction in a non-athletic population: a pilot study. J Thorac Dis (2017) 0.75
Smokefree legislation effects on respiratory and sensory disorders: A systematic review and meta-analysis. PLoS One (2017) 0.75
Airflow limitation following cardiopulmonary exercise testing and heavy-intensity intermittent exercise in children with cystic fibrosis. Eur J Pediatr (2014) 0.75
Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02
Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl (1993) 20.55
Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy (1977) 14.37
Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med (2000) 9.44
Development and validation of a questionnaire to measure asthma control. Eur Respir J (1999) 9.35
Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science (1998) 5.23
Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax (1978) 4.77
Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy (1977) 4.42
The perception of breathlessness in asthma. Am Rev Respir Dis (1982) 4.17
Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol (1981) 4.03
Comparison of bronchoconstriction induced by cycling and running. Thorax (1971) 4.00
Interpreting treatment effects in randomised trials. BMJ (1998) 3.97
Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl (1993) 3.82
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 3.69
Standardization of exercise tests in asthmatic children. Arch Dis Child (1972) 3.55
Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline. Br Med J (Clin Res Ed) (1981) 3.43
Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl (1993) 3.42
Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax (2008) 3.30
Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Official Statement of The European Respiratory Society. Eur Respir J (1995) 3.27
A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16
Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med (1994) 3.06
Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax (1981) 3.06
Lung volumes and forced ventilatory flows. Eur Respir J (1993) 3.00
Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist. N Engl J Med (1990) 2.80
Standardization of inhalation provocation tests: two techniques of aerosol generation and inhalation compared. Am Rev Respir Dis (1981) 2.75
Aetiological agents in occupational asthma. Eur Respir J (1994) 2.66
Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med (1998) 2.62
Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 2.58
Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update. Eur Respir J (2003) 2.57
Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med (1999) 2.53
Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax (1996) 2.52
CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 2.52
Rapid onset of tolerance to the bronchoprotective effect of salmeterol. Chest (1995) 2.47
Prevalence of bronchial hyperresponsiveness and asthma in a rural adult population. Thorax (1987) 2.37
The need to change the method for defining mild airway obstruction. Eur Respir J (2011) 2.30
Children and adult perceptions of childhood asthma. Pediatrics (1997) 2.25
Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis (1990) 2.23
Histamine dose-response curves in asthma: reproducibility and sensitivity of different indices to assess response. Thorax (1983) 2.22
Exercise-induced asthma. Br J Dis Chest (1975) 2.10
Evaluation of ultrasonically nebulised solutions for provocation testing in patients with asthma. Thorax (1983) 2.09
A longitudinal study of possible allergy to enzyme detergents. Clin Allergy (1985) 2.07
Comparison of histamine bronchial challenges with the Wright nebulizer and the dosimeter. Clin Allergy (1979) 2.07
[Comments on screening spirometry for detection of COPD]. Ned Tijdschr Geneeskd (2007) 2.06
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest (2001) 2.05
Late asthmatic responses. Am Rev Respir Dis (1987) 2.05
Fatal asthma attack during an inhalation challenge with ultrasonically nebulized distilled water. J Allergy Clin Immunol (1995) 2.04
Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis (1993) 2.02
Protective effect of drugs on histamine-induced asthma. Thorax (1977) 2.02
Roflumilast with long-acting β2-agonists for COPD: influence of exacerbation history. Eur Respir J (2011) 1.99
Studies in chronic allergic bronchopulmonary aspergillosis. 1. Clinical and physiological findings. Thorax (1977) 1.98
Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. Thorax (1992) 1.98
Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med (1999) 1.96
Occupational asthma. N Engl J Med (1995) 1.95
Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med (2000) 1.93
Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. Am J Physiol Lung Cell Mol Physiol (2002) 1.92
An exercise challenge protocol for epidemiological studies of asthma in children: comparison with histamine challenge. Eur Respir J (1994) 1.89
Neutrophilic infiltration within the airway smooth muscle in patients with COPD. Thorax (2004) 1.89
Exacerbations of Bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants. Am J Respir Crit Care Med (2001) 1.88
Importance of airway inflammation for hyperresponsiveness induced by ozone. Am Rev Respir Dis (1983) 1.85
Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients. Eur Respir J (2003) 1.84
Quality of life issues in women with vertebral fractures due to osteoporosis. Arthritis Rheum (1993) 1.80
Canadian Thoracic Society guidelines for occupational asthma. Can Respir J (1998) 1.80
Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. Am J Respir Crit Care Med (1997) 1.79
Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol (1987) 1.78
General practitioners' and practice nurses' knowledge of how much patients should and do drink. Br J Gen Pract (2001) 1.74
Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer. Eur Respir J (2007) 1.73
Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis. Clin Exp Allergy (1996) 1.72
Inhaled and oral salbutamol in exercise-induced asthma. Am Rev Respir Dis (1976) 1.72
Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med (1997) 1.71
Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med (1999) 1.69
Problems of interpreting exercise-induced asthma. J Allergy Clin Immunol (1973) 1.68
References values for forced spirometry. Group of the European Community Respiratory Health Survey. Eur Respir J (1998) 1.68
Relationship between quality of life and clinical status in asthma: a factor analysis. Eur Respir J (2004) 1.68
Is nedocromil sodium effective treatment for asthma? Eur Respir J (1993) 1.67
Rapid response of circulating myeloid dendritic cells to inhaled allergen in asthmatic subjects. Clin Exp Allergy (2002) 1.66
Standardization of inhalation provocation tests: influence of nebulizer output, particle size, and method of inhalation. J Allergy Clin Immunol (1981) 1.66
Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Chest (1996) 1.65
Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med (2001) 1.65
Is there a unifying hypothesis for exercise-induced asthma? J Allergy Clin Immunol (1984) 1.64
Incidence and determinants of IgE-mediated sensitization in apprentices. A prospective study. Am J Respir Crit Care Med (2000) 1.63
Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Am J Respir Crit Care Med (1995) 1.63
Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis (1987) 1.62
Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects. J Allergy Clin Immunol (1998) 1.62
Prevention of severe exercise-induced asthma with hot humid air. Lancet (1979) 1.61
Association between markers of emphysema and more severe chronic obstructive pulmonary disease. Thorax (2006) 1.60
Bronchial responsiveness to inhaled histamine and exercise. J Allergy Clin Immunol (1979) 1.60
Studies in chronic allergic bronchopulmonary aspergillosis. 2. Radiological findings. Thorax (1977) 1.60
Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids. Eur Respir J (2002) 1.59
Mechanism of perennial allergic asthma. Lancet (1983) 1.58